Project Grant S10OD034375
Award Date 8/1/24
Completion Date 7/31/25
Dollars Obligated $253K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
- The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP) awarded a $255,500 Project Grant (CFDA 93.351) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a new digital multi-isotope autoradiography system. This advanced imaging equipment will be housed at the Institute for Innovation in Imaging at MGH and will provide highly sensitive, real-time analysis of isotope distribution in tissue samples. The award,...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) provides $872,734 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to acquire a Leica Stellaris 8 Falcon confocal microscope. The new microscope will modernize the imaging platform at MGH's Center for Immunology and Inflammatory Diseases (CIID), replacing an aging confocal microscope that is no longer...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,485,000 Project Grant award from the Department of Health and Human Services National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award period runs from September 1, 2025 to August 31, 2028. The grant supports research focused on the discovery and characterization of programmable biological systems, particularly new RNA-guided functions found in...
- The National Institutes of Health (NIH) Office of Research Infrastructure Programs (ORIP), under the Research Infrastructure Programs (CFDA 93.351), awarded a $1,990,349 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to build and support a High-Performance Computing (HPC) cluster for computational pathology research. The project aims to address the growing need for enhanced data processing and analysis capabilities to support...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $161,169 Project Grant by the Office of the Director at the National Institutes of Health under the Research Infrastructure Programs (CFDA 93.351) to purchase a state-of-the-art metabolic/gas exchange system compatible with magnetic resonance imaging (MRI). This specialized equipment will enable a wide range of breath-by-breath gas exchange and pulmonary function measurements as well as...
- This $2,000,000 Project Grant awarded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) supports the upgrade and maintenance of a 14T/600 MHz high-field nuclear magnetic resonance (NMR) spectrometer and microimager at Massachusetts General Hospital (MGH). This cutting-edge biomedical research instrument has made significant contributions to diverse fields, including contrast agent development, tissue pathology, and the study of conditions like...
- The federal Project Grant award of $999,806.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to study innate lymphoid cells as new targets to reduce vascularized composite tissue transplant rejection. The award, which runs from September 30, 2024 to September 29, 2027, will enable MGH to conduct innovative biomedical research,...
- The federal Project Grant award of $992,302 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation". MGH, a...
- This Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $1,835,840 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to purchase a clinical-grade NVISION POLARIS C13 Polarizer. This instrument enables hyperpolarization of C13 substrates, providing over a 10,000-fold increase in MRI signal for metabolic imaging. The award will allow Massachusetts General Hospital to be the only...
- This federal Project Grant award of $382,381 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. The award period runs from September 1, 2025 to August 31, 2028. The grant supports advanced biomedical research by MGH aimed at developing innovative genetic immunodetection and treatment approaches for VCA (vascularized...